Organs-on-chips (OoCs) Technology for disease modeling, drug development and personalized medicine | Current Affairs | Vision IAS
News Today Logo

    Organs-on-chips (OoCs) Technology for disease modeling, drug development and personalized medicine

    Posted 17 Sep 2024

    2 min read

    Recent advancements in human-relevant 3D culture models, known as "new approach methods" (NAMs), provide promising new ways to develop more precise and effective treatments.

    • These models include 3D spheroids, organoids, bioprinting, and OoCs technology.

    What is OoCs technology?

    • It uses tiny fluid channels that simulate blood flow, oxygen delivery, nutrient transport etc. to create miniature models of biological organs (lung, heart etc.) on a chip-sized device.
      • These chips are made from living cells grown in a flexible material.

    Advantages of OoCs technologies 

    • Reduce animal testing: OoCs can replace the need for animal testing in some cases. 
    • More accurate biological responses:  Compared to traditional 2D cultures.

    Applications of Organ-on-chips (OoCs) technologies

    • Drug discovery:  Study the efficacy of drugs and can be used to screen and develop new drugs. 
    • Precision medicine: Develop personalized treatments for specific patients. 
    • Study disease mechanisms: Help understand how diseases work, and identify potential therapeutic targets. 
    • Study cell-cell interactions: Allowing researchers to study how cells interact with each other as it can sense and control the environment around living cells.

    Challenges associated with OoC Technology: Standardization of manufacturing processes; Lack of universally accepted protocols and materials, replicating full complexity of a human organ etc.

    Steps Taken for Promoting OoCs

    • Amendment of  New Drugs and Clinical Trials Rules 2019: to permit the use of human organs-on-chips and other NAMs prior to and in conjunction with animal testing when evaluating new drugs.
    • BioE3 policy: To drive innovation in the biotechnology sector, Key focus area of the policy is precision therapeutics.
    • Tags :
    • Organ-on-chips (OoCs)
    • New Drugs and Clinical Trials Rules 2019
    • BioE3 policy
    Watch News Today
    Subscribe for Premium Features

    Quick Start

    Use our Quick Start guide to learn about everything this platform can do for you.
    Get Started